Literature DB >> 8427405

Pancreatic insulinomas.

F Menegaux1, G Schmitt, M Mercadier, J P Chigot.   

Abstract

We report a series of 30 patients with pancreatic insulinoma treated from 1967 to 1990. Twenty-nine patients underwent surgery. In 24 patients, the lesion was a benign adenoma. The pancreatic lesion was localized preoperatively in 59% of cases (94% since 1980), and all lesions that were identifiable histologically were palpable intraoperatively. Endoscopic pancreatic ultrasonography, performed twice, appeared to be a very promising method of investigation. In the 24 patients with adenoma, 14 enucleations and 10 pancreatic resections were performed, with the enucleation rate increasing over time. One patient died during the postoperative period. Pancreatic fistulas (43%) were the most common cause of morbidity and were more common after enucleation (57% versus 29% after pancreatectomy). The mean follow-up period was 7 years. Excluding the patients with adenocarcinomas, the recovery rate was 92% (23 of 25 among whom 2 patients had transitory recurrent hypoglycemia), 2 patients who underwent corporeo-caudal pancreatectomy being diabetic (8%).

Entities:  

Mesh:

Year:  1993        PMID: 8427405     DOI: 10.1016/s0002-9610(05)80519-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  11 in total

1.  Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.

Authors:  Zina Meriden; Chanjuan Shi; Barish H Edil; Trevor Ellison; Christopher L Wolfgang; Toby C Cornish; Richard D Schulick; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2011-07       Impact factor: 6.394

Review 2.  Insulinoma: pathophysiology, localization and management.

Authors:  Joyce J Shin; Phillip Gorden; Steven K Libutti
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

3.  Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1.

Authors:  Laureano Fernández-Cruz; Isidro Martínez; Gleydson Cesar-Borges; Emiliano Astudillo; David Orduña; Irene Halperin; Gemma Sesmilo; Manuel Puig
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

4.  Malignant insulinoma causing liver metastasis 8 years after the initial surgery: report of a case.

Authors:  N Sata; W Kimura; T Kanazawa; T Muto
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 5.  Morphological and functional investigations of neuroendocrine tumors of the pancreas.

Authors:  Philippe L Pereira; Jakub Wiskirchen
Journal:  Eur Radiol       Date:  2003-05-06       Impact factor: 5.315

Review 6.  Insulinoma.

Authors:  Aarti Mathur; Philip Gorden; Steven K Libutti
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

7.  Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital.

Authors:  Mehrdad Nikfarjam; Andrew L Warshaw; Lloyd Axelrod; Vikram Deshpande; Sarah P Thayer; Cristina R Ferrone; Carlos Fernández-del Castillo
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

8.  Parenchyma-sparing resections for pancreatic neuroendocrine tumors.

Authors:  Rim Cherif; Sébastien Gaujoux; Anne Couvelard; Safi Dokmak; Marie-Pierre Vuillerme; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  J Gastrointest Surg       Date:  2012-08-22       Impact factor: 3.452

9.  Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.

Authors:  F W Winkelbauer; B Nierderle; O Graf; R Prokesch; S Thurnher; R Wildling; J Lammer
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

10.  Biliary obstruction due to pancreatic insulinoma.

Authors:  A Dhar; Y Chawla; R K Dhiman; S Suri; A Behera; A Bhansali; R Sud; R Katariya; J Dilawari
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.